Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study.

RuiJun Chen, Marc A Suchard, Harlan M Krumholz, Martijn J Schuemie, Steven Shea, Jon Duke, Nicole Pratt, Christian G Reich, David Madigan, Seng Chan You, Patrick B Ryan, George Hripcsak

September 2021 Hypertension

Synopsis of Social media discussions

Many discussions reference specific findings from the study, such as the lower risk of adverse effects like cough and angioedema with ARBs compared to ACE inhibitors. Phrases like 'safer option' and 'better side effect profile' are frequently used, reinforcing the perceived importance and applicability of the study's conclusions in clinical practice. Users also raise questions about personal preferences between the two classes of medication, showing a desire for more nuanced discussions, pointing to the study's impact on real-world treatment decisions.

A
Agreement
 Strong agreement

The majority of discussions reflect strong agreement with the findings, advocating for ARBs based on their safety profile compared to ACE inhibitors.

I
Interest
 High level of interest

Users express high interest in the efficacy and safety comparisons presented in the study, indicating its relevance to ongoing medical discussions.

E
Engagement
 Moderate level of engagement

While most posts are supportive, they tend to summarize key points rather than dive deeply into methodology or detailed implications.

I
Impact
 High level of impact

There's a strong perception that the study will influence prescribing practices, with several mentions highlighting its potential to shape patient care.

Social Mentions

YouTube

2 Videos

Bluesky

3 Posts

Facebook

4 Posts

Twitter

171 Posts

Blogs

5 Articles

News

52 Articles

Metrics

Video Views

4,080,155

Total Likes

46,847

Extended Reach

5,148,558

Social Features

237

Timeline: Posts about article

Top Social Media Posts

Posts referencing the article

Comparative Safety of Blood Pressure Medications for 2024

Comparative Safety of Blood Pressure Medications for 2024

Which blood pressure medicine is the safest? This video compares the effectiveness and safety of ACE inhibitors and Angiotensin Receptor Blockers, helping you make informed decisions about your blood pressure medication. Avoid risks associated with the wrong choices.

KenDBerryMD

July 27, 2021

4,079,084 views

Никита Рашкин

August 30, 2024

1,071 views

  • Sayed S. Rahman
    @SayedSRahman1 (Twitter)

    RT @edgarvlermamd: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors (ACEi) and Angiotensin…
    view full post

    March 16, 2025

    6

  • Dr. Oriba Dan Langoya
    @DrOribaDan (Twitter)

    RT @edgarvlermamd: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors (ACEi) and Angiotensin…
    view full post

    March 13, 2025

    6

  • diacavan
    @diacavan (Twitter)

    RT @edgarvlermamd: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors (ACEi) and Angiotensin…
    view full post

    March 12, 2025

    6

  • Lê Văn Lắm
    @levanlam95 (Twitter)

    Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Studyhttps://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.120.16667
    view full post

    March 12, 2025

  • Jean Nzambaza
    @NZAMBAZAJean (Twitter)

    RT @edgarvlermamd: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors (ACEi) and Angiotensin…
    view full post

    March 12, 2025

    6

  • Rafael López Márquez
    @RafaelLpezMrqu2 (Twitter)

    RT @edgarvlermamd: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors (ACEi) and Angiotensin…
    view full post

    March 12, 2025

    6

  • Ye M. Tun, MD FACP
    @DrYeMyintTun (Twitter)

    RT @edgarvlermamd: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors (ACEi) and Angiotensin…
    view full post

    March 12, 2025

    6

  • Edgar V. Lerma
    @edgarvlermamd.bsky.social (Bluesky)

    Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors (ACEi) and Angiotensin Receptor Blockers (ARBs): A Multinational Cohort Study ca. 2021 #Nephpearls #NephSky
    view full post

    March 12, 2025

    1

    1

  • Edgar V. Lerma
    @edgarvlermamd.bsky.social (Bluesky)

    Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors (ACEi) and Angiotensin Receptor Blockers (ARBs): A Multinational Cohort Study ca. 2021 #Nephpearls #NephSky
    view full post

    March 12, 2025

    1

  • Edgar V. Lerma
    @edgarvlermamd (Twitter)

    Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors (ACEi) and Angiotensin Receptor Blockers (ARBs): A Multinational Cohort Study ca. 2021 #Nephpearls
    view full post

    March 12, 2025

    26

    6

  • Edgar V. Lerma
    @edgarvlermamd (Twitter)

    Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors (ACEi) and Angiotensin Receptor Blockers (ARBs): A Multinational Cohort Study ca. 2021 from #Nephpearls
    view full post

    March 12, 2025

  • Edgar V. Lerma
    @edgarvlermamd (Twitter)

    Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors (ACEi) and Angiotensin Receptor Blockers (ARBs): A Multinational Cohort Study ca. 2021 from #Nephpearls
    view full post

    March 12, 2025

    3

  • Kenneth Cook
    @KennethCoo6145 (Twitter)

    Safest BLOOD PRESSURE Medications in 2024 https://t.co/9xxkwsfb29 via @YouTube
    view full post

    September 16, 2024

  • Gaigous
    @Gaigous (Twitter)

    @CatNameIsShadow https://t.co/uoHfoIHtci
    view full post

    June 5, 2024

    1

  • よっこ医しょういち
    @eigodojoau (Twitter)

    一番安全な降圧剤はARBですよという単純な内容。医者はじめ英語ができる医療従事者には1.5倍速でも聴いて分かるけど、非医療従事者にはたぶん難しくてわからないという例の一つ Safest BLOOD PRESSURE Medications in 2024 https://t.co/GeApjSJfQl
    view full post

    March 27, 2024

    3

  • Su(Matt)riptan
    @Ambcare_pharmer (Twitter)

    @mendesthiagob @eva3034385615 I'm sure there are some specific instances Ace may be preferred. There are some larger comparisons done. One here: https://t.co/wSL9kS9qeU I think some of the early ace trials showed a more pronunced outcome effect but their background meds and baseline bps were different.
    view full post

    September 18, 2023

    1

  • Dr t imhoff
    @MotleyRx (Twitter)

    @Schloss_PharmD @Gabby_Brauner27 https://t.co/QK6usKLAKt
    view full post

    July 21, 2023

  • Donald H. Marks:Physician scientist ⚕️☕
    @Donald_H_Marks (Twitter)

    Very nice short YouTube video on the different classes of high blood pressure medicines and which ones are the safest. https://t.co/V5GbKZmpsK
    view full post

    July 10, 2023

  • Simple Man
    @Simple_Man182 (Twitter)

    @andrea99960851 https://t.co/BpK6tA5Tpt
    view full post

    June 11, 2023

  • angelzahra alimadad
    @angelzahraalim1 (Twitter)

    RT @medsanmedicine: اگرچه دارودسته ACE ظاهرا محبوب‌تر هستند اما تیم ARB کاری‌تر هستند ولی ... با سایدافکت بالاتر https://t.co/N90AOTtvA9 h…
    view full post

    June 10, 2023

    2

  • Kim possible
    @Kimyfarrahfowlr (Twitter)

    RT @medsanmedicine: اگرچه دارودسته ACE ظاهرا محبوب‌تر هستند اما تیم ARB کاری‌تر هستند ولی ... با سایدافکت بالاتر https://t.co/N90AOTtvA9 h…
    view full post

    June 10, 2023

    2

  • Saeed
    @medsanmedicine (Twitter)

    اگرچه دارودسته ACE ظاهرا محبوب‌تر هستند اما تیم ARB کاری‌تر هستند ولی ... با سایدافکت بالاتر https://t.co/N90AOTtvA9 https://t.co/tGNlduth2q
    view full post

    June 10, 2023

    76

    2

  • Jim Furr
    @jimfurr (Twitter)

    https://t.co/vGIX4QB9cY
    view full post

    April 12, 2023

    1

  • Gurminder Khamba
    @Gurmstar (Twitter)

    @ChristosArgyrop @tulunsokit @WaliNuri @hswapnil @kidney_boy @AnnaGaddy @gratefull080504 @Nephro_Sparks @ALTAREQ_007 @jamiekwillows @hellokidneyMD @NephroSeeker @NephJC @brendonneuen But they are close, now personally go for Arb as first line, don’t want pts rejecting this class due to a Cough
    view full post

    April 4, 2023

    2

  • UConn Waterbury Internal Medicine Residency
    @UConnwIM (Twitter)

    #outpatient What is your favorite initial BP treatment combination? Do you prefer ACE or ARB? Which agent is better? You have questions and we have the answers! Take a look at this article to learn more and share your thoughts in the comments. https://t.co/rmqvJthcMn
    view full post

    March 28, 2023

  • Dirk Bruere
    @DirkBruere (Twitter)

    https://t.co/dsG1YvZE8W
    view full post

    March 11, 2023

  • Ron Jacob
    @RonRafjake (Twitter)

    Safest BLOOD PRESSURE Medications in 2023 https://t.co/yPzg9h4rU0 via @YouTube
    view full post

    February 26, 2023

  • #HelpYouGetGAINS
    @helpYOUgetGAINS (Twitter)

    Safest BLOOD PRESSURE Medications in 2023 https://t.co/rxmDI5jsnt via @YouTube https://t.co/iw16MjLE9l
    view full post

    February 25, 2023

  • OlgaDunaeva
    @DunyaOlga (Twitter)

    RT @HyperAHA: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Bl…
    view full post

    February 17, 2023

    13

  • kintya
    @kintya2 (Twitter)

    ACE-IもARBも差がないというmeta解析もあるのだが… https://t.co/IPFQ2PSWPz
    view full post

    November 28, 2022

    1

  • Mark Wade
    @BlueMarbleMark (Twitter)

    @ScottAdamsSays This doctor looks for alternatives to standard BP meds. This vid covers meds but he has more. Recent changes to BP numbers trigger a med approach. Check the history. Be safe amigo https://t.co/lQ5KCiHw8R
    view full post

    October 25, 2022

  • Rijk Gans
    @Gansrob (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    October 18, 2022

    27

  • waqar dahri
    @Dahri85Waqar (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    October 14, 2022

    27

  • Derek Smith
    @derekedsmith (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    October 11, 2022

    27

  • BowTiedLoon | Degen Island Physician
    @BowTiedLoon (Twitter)

    A good clue that your doctor is outdated is if they suggest an ACE inhibitor over an ARB for hypertension. https://t.co/Tt5YvvKGQX
    view full post

    September 30, 2022

    2

  • Sebastian Meritless Tickbox Fasttrack-Blythe
    @Jason_MI5 (Twitter)

    @NPR Safest BLOOD PRESSURE Medications in 2022 https://t.co/jAupZFoIQI via @YouTube
    view full post

    September 25, 2022

  • 不思議の国のとら子
    @miss_proton (Twitter)

    RT @Darbepoeti_n: 高血圧患者を対象とし、ACE阻害薬とARBの作用/副作用を直接比較した試験は少ない。この多国コホート研究によると、両剤の心血管保護作用に差はなく、ARBの方が咳や血管浮腫などの副作用が少ないことがわかった。 安全性という点ではやはりARBが…
    view full post

    July 24, 2022

    12

  • Dr. Murli Prasad Sharma
    @DrMurliPrasad (Twitter)

    RT @AdiG1993: 2021 trial comparing ACEi vs ARB as first line drug for newly dx HTN (within 1 year). They seem to have similar efficacy as…
    view full post

    July 22, 2022

    2

  • .
    @AdiG1993 (Twitter)

    2021 trial comparing ACEi vs ARB as first line drug for newly dx HTN (within 1 year). They seem to have similar efficacy as a class. But ARBs have lesser AE --> heart failure, stroke or AMI! ACEi --> more chances of pancreatitis and GI bleed! https://t.co/vPU6lhH7hb
    view full post

    July 22, 2022

    21

    2

  • Nick Murray
    @NickMurray_ (Twitter)

    ARB = ACE-I, but better side effect profile: lower risk for acute pancreatitis, angioedema, cough, and GI bleed. Shifting preference toward ARBS
    view full post

    June 26, 2022

  • DEAR DIARY
    @GgossJm (Twitter)

    Safest BLOOD PRESSURE Medications in 2022 https://t.co/2x12KPzkuV via @YouTube
    view full post

    May 28, 2022

  • Just Raz
    @justRaz86 (Twitter)

    @MatthewHoMD 1 last thing, in my practice I favor ARBs over ACEs with the better side effect profile https://t.co/pnTvBNZP4x
    view full post

    April 30, 2022

    1

  • りれいゆ　(　RIREIYU　)
    @x4Fd3n2z76im0Vw (Twitter)

    RT @Darbepoeti_n: 高血圧患者を対象とし、ACE阻害薬とARBの作用/副作用を直接比較した試験は少ない。この多国コホート研究によると、両剤の心血管保護作用に差はなく、ARBの方が咳や血管浮腫などの副作用が少ないことがわかった。 安全性という点ではやはりARBが…
    view full post

    April 25, 2022

    12

  • GregG
    @GregG17241340 (Twitter)

    @PeterAttiaMD ACE Inhibitors bad news - https://t.co/cDkG9GkQvA
    view full post

    March 24, 2022

  • GregG
    @GregG17241340 (Twitter)

    @kevinnbass ACE Inhibitors bad news. https://t.co/cDkG9GkQvA
    view full post

    March 24, 2022

  • Evandro Martins F. MD
    @evandrofilhobr (Twitter)

    @drandrewsharp Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study https://t.co/TXAUiFYdpC
    view full post

    March 11, 2022

  • Andrew Sharp
    @drandrewsharp (Twitter)

    @evandrofilhobr https://t.co/O9rnEsAWNa https://t.co/Plk0CVbzab
    view full post

    March 11, 2022

    5

  • Jonathan Vo
    @jonathandvvo (Twitter)

    RT @Whale_Mockery: @emily_fri No reason. https://t.co/emlILmCnQx
    view full post

    March 11, 2022

    1

  • ¡Will!
    @Whale_Mockery (Twitter)

    @emily_fri No reason. https://t.co/emlILmCnQx
    view full post

    March 11, 2022

    15

    1

  • Njut Tabi Godlove
    @masecdante (Twitter)


    view full post

    March 11, 2022

  • just another Nikos
    @another_nikos (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    February 7, 2022

    27

  • Phenol
    @xyz_2358 (Twitter)

    https://t.co/jeH2e0s90f
    view full post

    November 17, 2021

    1

  • 循環器記事エビデンスメモ
    @3333333fr (Twitter)

    2 different time-at-risk windows: on-treatment and intent-to-treat. https://t.co/MYFkVKj8Qy
    view full post

    November 1, 2021

  • 循環器記事エビデンスメモ
    @3333333fr (Twitter)

    Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study https://t.co/MYFkVKj8Qy
    view full post

    October 31, 2021

  • cardio (Nijad Bakhshaliyev)
    @drnijad (Twitter)

    ARBs or ACEIs for 1 line tx for HTN? ARB vs. ACEI Similar primary efficacy (MI, Stroke, HF and composite), but ARBs had better safety profile than ACEIs. ARBs seem superior to ACEIs in 1st-line tx for HTN. @CircAHA @AHAScience #hypertension https://t.co/5Ervrj89nC
    view full post

    October 29, 2021

    3

  • Altamiro Bottino
    @BottinoAltamiro (Twitter)

    Among effective antihypertensive drugs, less popular choice is slightly safer https://t.co/7niwTOhriT https://t.co/USuDL6rIey https://t.co/ySdiKMPBXA
    view full post

    October 16, 2021

  • FUNDAPROCECA
    @FUNDAPROCECA (Twitter)

    RT @igormorr: Quién es mejor? IECAS VS Bras . Ve aquí el resultado Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Conv…
    view full post

    October 9, 2021

    5

  • yolimar meza
    @meza0208 (Twitter)

    RT @igormorr: Quién es mejor? IECAS VS Bras . Ve aquí el resultado Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Conv…
    view full post

    October 9, 2021

    5

  • SALUD TOTAL
    @MiSaludTotal (Twitter)

    RT @igormorr: Quién es mejor? IECAS VS Bras . Ve aquí el resultado Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Conv…
    view full post

    October 9, 2021

    5

  • Ivan Mendoza
    @mencardio (Twitter)

    RT @igormorr: Quién es mejor? IECAS VS Bras . Ve aquí el resultado Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Conv…
    view full post

    October 8, 2021

    5

  • Igor Morr
    @igormorr (Twitter)

    RT @igormorr: Quién es mejor? IECAS VS Bras . Ve aquí el resultado Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Conv…
    view full post

    October 8, 2021

    5

  • Igor Morr
    @igormorr (Twitter)

    Quién es mejor? IECAS VS Bras . Ve aquí el resultado Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study https://t.co/SQ7mdME777 @svhipertension @mencardio @meza0208
    view full post

    October 6, 2021

    8

    5

  • Andrew Michael South, MD, MS
    @asouth_neph (Twitter)

    We can and should do this study in #Hypertension #Pediatric #PedHTN Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study https://t.co/8r68T74EZF
    view full post

    October 5, 2021

  • 帰ってきたせきねつる@お休み中
    @sekineturu (Twitter)

    RT @Darbepoeti_n: 高血圧患者を対象とし、ACE阻害薬とARBの作用/副作用を直接比較した試験は少ない。この多国コホート研究によると、両剤の心血管保護作用に差はなく、ARBの方が咳や血管浮腫などの副作用が少ないことがわかった。 安全性という点ではやはりARBが…
    view full post

    September 30, 2021

    12

  • Laurenza
    @laurenzakyle (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 30, 2021

    27

  • Alexander Kupis
    @AlexanderKupis (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 30, 2021

    27

  • Pedro Abi-Kair Borges Calomeni
    @pedro_calomeni (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 30, 2021

    27

  • Brandon Dixon, MD, PhD
    @Dixon_BrandonJ (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 30, 2021

    27

  • Sharon OJ, MD
    @sostfeldjohns (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 30, 2021

    27

  • Kovacs
    @king_tayedavid (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 30, 2021

    27

  • JS Deveault
    @jeansdev (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 30, 2021

    27

  • Michael Burk, MD
    @MJBurkMD (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 30, 2021

    27

  • Electrolyte Doc
    @DocElectrolyte (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 30, 2021

    27

  • Ayaz Ali Leghari
    @AyazAliLeghari1 (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 30, 2021

    27

  • Alfa
    @AlfasaurioAlfa (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 30, 2021

    27

  • Piyush
    @drpiyushkr (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 30, 2021

    27

  • Fang3536
    @Fang35361 (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 30, 2021

    27

  • Navdeep Sekhon
    @NavdeepSekhon2 (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 29, 2021

    27

  • INNOVACIONES
    @foxmackalister (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 29, 2021

    27

  • Mark Heslin
    @Mark_Heslin (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 29, 2021

    27

  • Linda Vaillant
    @lvaillant (Twitter)

    RT @pharmaciensAPES: Étude qui compare les IECA et les ARA en 1ere ligne de traitement en regard de l’efficacité et de la sécurité. https:/…
    view full post

    September 29, 2021

    1

  • Chase Lewellen
    @ChaseLewellen (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 29, 2021

    27

  • Med Peds Hospitalist
    @medpedshosp (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 29, 2021

    27

  • Richard Clapp
    @richclapp12 (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 29, 2021

    27

  • TH Panagiotakis, MD
    @HPanagiotakis (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 29, 2021

    27

  • Marc Bern
    @barron_john05 (Twitter)

    RT @sargsyanz: "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losa…
    view full post

    September 29, 2021

    27

  • Zaven Sargsyan
    @sargsyanz (Twitter)

    "Consider preferentially starting ARBs rather than ACE inhibitors when initiating treatment for hypertension" Now that losartan is a 4-dollar-generic, I'm tempted to agree... https://t.co/9PHLYqIUyv
    view full post

    September 29, 2021

    137

    27

  • pharmaciensAPES
    @pharmaciensAPES (Twitter)

    Étude qui compare les IECA et les ARA en 1ere ligne de traitement en regard de l’efficacité et de la sécurité. https://t.co/zpnwxYjxcI https://t.co/aDkm7zpJnw
    view full post

    September 29, 2021

    1

    1

  • John Damianos, M.D.
    @john_damianosMD (Twitter)

    ARBs: just as effective as ACE inhibitors and fewer side effects. #medtwitter #medicine #hypertension #cardiology #cardiotwitter #nephrology #nephtwitter https://t.co/M3kxp2nTgt
    view full post

    September 25, 2021

    4

    1

  • pinacol
    @pinacol (Twitter)

    ACE阻害薬とARBの有効性に違いがなかったという結果よりも、ACE阻害薬が膵炎や消化管出血のリスクになることの方に目がいってしまった。 https://t.co/fc3ecHb1GH
    view full post

    September 24, 2021

    2

    1

  • Doug Tam, PharmD
    @drugtam (Twitter)

    ARB starts?
    view full post

    September 13, 2021

  • くに
    @daipc0203 (Twitter)

    RT @Fizz_DI: 高血圧に対するACE阻害薬とARBの単剤治療を比較した多国籍コホート研究。 ・心血管保護効果に差はなさそう 心筋梗塞：HR=1.11 [95%CI:0.95-1.32] 心不全：HR=1.03 [95%CI:0.87-1.24] 脳卒中：HR=1.0…
    view full post

    September 9, 2021

    4

  • 平河廣海@薬剤師、薬ゴロ、小説、政治
    @AgAgDR1 (Twitter)

    RT @Fizz_DI: 高血圧に対するACE阻害薬とARBの単剤治療を比較した多国籍コホート研究。 ・心血管保護効果に差はなさそう 心筋梗塞：HR=1.11 [95%CI:0.95-1.32] 心不全：HR=1.03 [95%CI:0.87-1.24] 脳卒中：HR=1.0…
    view full post

    September 8, 2021

    4

  • yusuke0406
    @yusuke04061 (Twitter)

    RT @Fizz_DI: 高血圧に対するACE阻害薬とARBの単剤治療を比較した多国籍コホート研究。 ・心血管保護効果に差はなさそう 心筋梗塞：HR=1.11 [95%CI:0.95-1.32] 心不全：HR=1.03 [95%CI:0.87-1.24] 脳卒中：HR=1.0…
    view full post

    September 8, 2021

    4

  • Fizz-DI＠比較と使い分け-KOJIMA Yushi
    @Fizz_DI (Twitter)

    高血圧に対するACE阻害薬とARBの単剤治療を比較した多国籍コホート研究。 ・心血管保護効果に差はなさそう 心筋梗塞：HR=1.11 [95%CI:0.95-1.32] 心不全：HR=1.03 [95%CI:0.87-1.24] 脳卒中：HR=1.07 [95%CI:0.91-1.27] Hypertension.78(3):591-603,(2021) PMID:34304580 https://t.co/XfcFVMS557
    view full post

    September 8, 2021

    16

    4

  • Anna Dominiczak
    @UofGRegiusAnna (Twitter)

    RT @HyperAHA: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Bl…
    view full post

    September 8, 2021

    13

  • Carlos Godoy Rivas, MD
    @CGR_MD (Twitter)

    RT @HyperAHA: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Bl…
    view full post

    September 4, 2021

    13

  • Scott Cameron
    @2Scottish (Twitter)

    https://t.co/s6PTTA43Es https://t.co/efUkI6lJqR
    view full post

    September 4, 2021

    2

  • CNCFCardio
    @CNCFCardio (Twitter)

    RT @HyperAHA: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Bl…
    view full post

    September 4, 2021

    13

  • CardioAcademic
    @CardioAcademic (Twitter)

    RT @HyperAHA: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Bl…
    view full post

    September 4, 2021

    13

  • Dr. ViveK Nuktey
    @NukteVivek (Twitter)

    RT @HyperAHA: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Bl…
    view full post

    September 4, 2021

    13

  • PharmaDecisions LLC
    @PharmaDecisions (Twitter)

    RT @HyperAHA: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Bl…
    view full post

    September 3, 2021

    13

  • nawalbasri
    @nawalbasri1 (Twitter)

    RT @HyperAHA: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Bl…
    view full post

    September 3, 2021

    13

  • Harlan Krumholz
    @hmkyale (Twitter)

    RT @HyperAHA: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Bl…
    view full post

    September 3, 2021

    13

  • Laure Rouch
    @RouchLaure (Twitter)

    RT @HyperAHA: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Bl…
    view full post

    September 3, 2021

    13

  • Giulia Rivasi
    @RivasiGiulia (Twitter)

    RT @HyperAHA: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Bl…
    view full post

    September 3, 2021

    13

  • شمس ✪
    @SHMS_SA (Twitter)

    RT @HyperAHA: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Bl…
    view full post

    September 2, 2021

    13

  • Hypertension
    @HyperAHA (Twitter)

    Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study. @hmkyale https://t.co/roQKHd5IYG https://t.co/JA7ysEoHHs
    view full post

    September 2, 2021

    22

    13


  • @akalayci34 (Twitter)

    https://t.co/71wQHba5ol
    view full post

    August 30, 2021

  • Alosa Health
    @AlosaHealth (Twitter)

    #ARBs and #ACE inhibitors are similarly effective as first-line treatments for #hypertension in new multinational #realworld study @HyperAHA, but the safety profile is better for ARBs. @ColumbiaDBMI @UCLAFSPH @YaleCardiology @suchard_group @hmkyale https://t.co/ZPHNNmzqPU
    view full post

    August 24, 2021

    2

  • John P Erwin III MD MBA MACC (#BigPoppy )
    @HeartOTXHeartMD (Twitter)

    “Across secondary and safety outcomes, patients on #ARBs had significantly lower risk of angioedema, cough, pancreatitis, and GI bleeding.” No difference in primary endpoints between #ACEi and #ARB #HTN https://t.co/5XpWIPwoq2
    view full post

    August 12, 2021

    2

  • Luis Tobajas Belvís
    @luisotobajas (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    August 4, 2021

    32

  • Carlos Andres
    @GilgameshAZ (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    August 3, 2021

    32

  • SEMERGEN | Médicos de AP #SEMERGEN25
    @SEMERGENap (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    August 3, 2021

    32

  • Servei de Farmàcia Parc Taulí
    @FarmaciaTauli (Twitter)

    RT @petita_libelula: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Rece…
    view full post

    August 2, 2021

    1

  • Sara Ortonobes
    @petita_libelula (Twitter)

    Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study https://t.co/M9VvFQzCqv
    view full post

    August 2, 2021

    1

  • Andrew Michael South, MD, MS
    @asouth_neph (Twitter)

    RT @ASPNeph: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blo…
    view full post

    August 1, 2021

    2

  • Dark Brandon Rises
    @iamgabbarson (Twitter)

    RT @ASPNeph: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blo…
    view full post

    August 1, 2021

    2

  • American Society of Pediatric Nephrology
    @ASPNeph (Twitter)

    Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study https://t.co/F8SAz8qrwL @HyperAHA #RAAS 3Hypertension #OpenAccess
    view full post

    August 1, 2021

    2

    2

  • #HelpYouGetGAINS
    @helpYOUgetGAINS (Twitter)

    Safest BLOOD PRESSURE Medications in 2021 https://t.co/rxmDI5jsnt via @YouTube https://t.co/1jmB4AICE7
    view full post

    July 31, 2021

  • Ernesto Rodríguez H
    @ernestocardio (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 31, 2021

    32

  • Adrian Naranjo Dominguez
    @DrAdrianNaranjo (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 31, 2021

    32

  • Vicente Pallares
    @vic_pallares (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 31, 2021

    32

  • Italo Kumamoto
    @fikkumamoto (Twitter)

    Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study https://t.co/ZoUu83VMi1
    view full post

    July 30, 2021

    1

  • Dr Shraboni Ghosal, PhD
    @ShraboniGhosal (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 30, 2021

    32

  • ☫кептагоп™Я☫
    @kentaron1971 (Twitter)

    RT @Darbepoeti_n: 高血圧患者を対象とし、ACE阻害薬とARBの作用/副作用を直接比較した試験は少ない。この多国コホート研究によると、両剤の心血管保護作用に差はなく、ARBの方が咳や血管浮腫などの副作用が少ないことがわかった。 安全性という点ではやはりARBが…
    view full post

    July 30, 2021

    12

  • 横山暁子
    @yokoakipp (Twitter)

    RT @Darbepoeti_n: 高血圧患者を対象とし、ACE阻害薬とARBの作用/副作用を直接比較した試験は少ない。この多国コホート研究によると、両剤の心血管保護作用に差はなく、ARBの方が咳や血管浮腫などの副作用が少ないことがわかった。 安全性という点ではやはりARBが…
    view full post

    July 30, 2021

    12

  • Cardiología Dénia
    @Cardio_Denia (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 30, 2021

    32

  • Servei de Farmàcia Parc Taulí
    @FarmaciaTauli (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 30, 2021

    32

  • 腎臓内科医のつぶやき
    @Cpe0CQy90m7HMXy (Twitter)

    RT @Darbepoeti_n: 高血圧患者を対象とし、ACE阻害薬とARBの作用/副作用を直接比較した試験は少ない。この多国コホート研究によると、両剤の心血管保護作用に差はなく、ARBの方が咳や血管浮腫などの副作用が少ないことがわかった。 安全性という点ではやはりARBが…
    view full post

    July 30, 2021

    12

  • KOW
    @wadakow1962 (Twitter)

    RT @Darbepoeti_n: 高血圧患者を対象とし、ACE阻害薬とARBの作用/副作用を直接比較した試験は少ない。この多国コホート研究によると、両剤の心血管保護作用に差はなく、ARBの方が咳や血管浮腫などの副作用が少ないことがわかった。 安全性という点ではやはりARBが…
    view full post

    July 30, 2021

    12

  • Ryo Horita, MD.
    @hrt01a (Twitter)

    RT @Darbepoeti_n: 高血圧患者を対象とし、ACE阻害薬とARBの作用/副作用を直接比較した試験は少ない。この多国コホート研究によると、両剤の心血管保護作用に差はなく、ARBの方が咳や血管浮腫などの副作用が少ないことがわかった。 安全性という点ではやはりARBが…
    view full post

    July 30, 2021

    12

  • Miu miu
    @JennifferBC (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 30, 2021

    32

  • Eduar Ordoñez
    @EduarOrdoez3 (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 30, 2021

    32

  • DΣMӨПIӨ ᄃЦΛƬΣЯПΛЯIӨ
    @candegris (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 30, 2021

    32

  • Elvia Cuauro
    @elvia_cuauro (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 30, 2021

    32

  • 色々自粛中(ガラス細工の様な繊細なハートを持つ貴公子
    @ECGEPSCADEVICE (Twitter)

    RT @Darbepoeti_n: 高血圧患者を対象とし、ACE阻害薬とARBの作用/副作用を直接比較した試験は少ない。この多国コホート研究によると、両剤の心血管保護作用に差はなく、ARBの方が咳や血管浮腫などの副作用が少ないことがわかった。 安全性という点ではやはりARBが…
    view full post

    July 30, 2021

    12

  • Humberto Blanco
    @humbertoblancoj (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 30, 2021

    32

  • Marta Florit
    @MartaFloritS (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 30, 2021

    32

  • José Mª Gª Quintana
    @jose_g_quintana (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 30, 2021

    32

  • Miguel Azañedo V
    @MikeMD2486 (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 29, 2021

    32

  • William
    @Milligw (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 29, 2021

    32

  • JsDs
    @eldostorjose (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 29, 2021

    32

  • Raul Fonseca
    @Rulex74c (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 29, 2021

    32

  • Adrián Rodríguez Córdoba
    @adrianhidrico (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 29, 2021

    32

  • medical user
    @UserMedical (Twitter)

    RT @Darbepoeti_n: 高血圧患者を対象とし、ACE阻害薬とARBの作用/副作用を直接比較した試験は少ない。この多国コホート研究によると、両剤の心血管保護作用に差はなく、ARBの方が咳や血管浮腫などの副作用が少ないことがわかった。 安全性という点ではやはりARBが…
    view full post

    July 29, 2021

    12

  • 佐藤 文俊|訪問看護の情報発信
    @fumitoshi_MW (Twitter)

    RT @Darbepoeti_n: 高血圧患者を対象とし、ACE阻害薬とARBの作用/副作用を直接比較した試験は少ない。この多国コホート研究によると、両剤の心血管保護作用に差はなく、ARBの方が咳や血管浮腫などの副作用が少ないことがわかった。 安全性という点ではやはりARBが…
    view full post

    July 29, 2021

    12

  • Gabriela Sánchez E.
    @gsestanga (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 29, 2021

    32

  • だるべ（腎臓内科）
    @Darbepoeti_n (Twitter)

    高血圧患者を対象とし、ACE阻害薬とARBの作用/副作用を直接比較した試験は少ない。この多国コホート研究によると、両剤の心血管保護作用に差はなく、ARBの方が咳や血管浮腫などの副作用が少ないことがわかった。 安全性という点ではやはりARBが選ばれやすいようですね。 https://t.co/TMnnLmFw0L
    view full post

    July 29, 2021

    95

    12

  • Juan Simón Sucre Viloria
    @juan_ssucre (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 29, 2021

    32

  • RafaelMMicø
    @rafamanuEl68 (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 29, 2021

    32

  • Rubén Martín
    @RubenMatins (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 29, 2021

    32

  • María del Pilar Pacheco Pilco
    @Mariade79672003 (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 29, 2021

    32

  • jabar
    @turilrh (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 29, 2021

    32

  • Manuel Méndez
    @mendez_bailon (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 29, 2021

    32

  • Juanmarcosgg
    @juanmarcosgg (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 29, 2021

    32

  • Sergio Zúñiga
    @medicosergio (Twitter)

    RT @Cardio_delaGuia: Los #ARBs vs #IECAs en terapia #HTA:
    view full post

    July 29, 2021

    32

  • Allan Böhm
    @Allan_Bohm (Twitter)

    Hmm, does this large, multi-national but observational study https://t.co/8oCZSVMnlf persuade you to prefer ARB before ACE-I for #hypertension ? #ESCYoung #wondrmedical
    view full post

    July 28, 2021

    1

  • Michal Červienka
    @MichalCervienka (Twitter)

    RT @kdjhaveri: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor B…
    view full post

    July 28, 2021

    2

  • David Rosenthal
    @adobefalls (Twitter)

    RT @kdjhaveri: Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor B…
    view full post

    July 28, 2021

    2

  • Kenar Jhaveri, MD
    @kdjhaveri.bsky.social (Bluesky)

    Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study. https://www.ahajournals.org/doi/abs/10.1161/HYPERTENSIONAHA.120.16667
    view full post

    July 28, 2021

  • Kenar Jhaveri
    @kdjhaveri (Twitter)

    Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study. https://t.co/6r3NBs5S7s
    view full post

    July 28, 2021

    2

    2

  • @investigando
    @rocatanho (Twitter)

    BRA no diferirían en efectividad vs IECA para la hipertensión pero presentarían un mejor perfil de seguridad, sin diferencia en el IM agudo, IC o ictus, BRA tendrían menor riesgo de angioedema, tos, pancreatitis y sangrado GI https://t.co/wuAMhwPIWK
    view full post

    July 28, 2021

  • Linda
    @ChefLippincott (Twitter)

    RT @KenDBerryMD: Is your BLOOD PRESSURE Medication Safe?? Here's the List... Watch: https://t.co/zgO1MFnoiy #highbloodpressure #highblood…
    view full post

    July 27, 2021

    4

  • Tyrone Bush
    @tb0ne2u (Twitter)

    Safest BLOOD PRESSURE Medications in 2021 https://t.co/XtTJjqNqWd via @YouTube
    view full post

    July 27, 2021

  • Josh Boals
    @jabtiger50 (Twitter)

    RT @KenDBerryMD: Is your BLOOD PRESSURE Medication Safe?? Here's the List... Watch: https://t.co/zgO1MFnoiy #highbloodpressure #highblood…
    view full post

    July 27, 2021

    4

  • Sue
    @Diamondkfarms (Twitter)

    RT @KenDBerryMD: Is your BLOOD PRESSURE Medication Safe?? Here's the List... Watch: https://t.co/zgO1MFnoiy #highbloodpressure #highblood…
    view full post

    July 27, 2021

    4

  • Ken D Berry MD
    @KenDBerryMD (Twitter)

    Is your BLOOD PRESSURE Medication Safe?? Here's the List... Watch: https://t.co/zgO1MFnoiy #highbloodpressure #highblood #hypertension #hypertensionawareness https://t.co/RiBan7enyI
    view full post

    July 27, 2021

    35

    4

  • RebeccaLee
    @MatriarchOMany (Twitter)

    Safest BLOOD PRESSURE Medications in 2021 https://t.co/3DCN6asXEb via @YouTube
    view full post

    July 27, 2021

  • Agingdoc
    @agingdoc1 (Twitter)

    Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study Supports prescribing ARBs over ACE-s when initiating Rx for HTN d/t a small safety advantage. https://t.co/w0kjGcpacn
    view full post

    July 27, 2021

    2

    1

  • 猫になりたい薬剤師
    @Vannyamoto (Twitter)

    RT @Office_j: 有害事象はARB群で有意に少。 https://t.co/kCIIgLQYyf
    view full post

    July 26, 2021

    1

  • 宇津 貴史 /Utsu, Takashi
    @Office_j (Twitter)

    有害事象はARB群で有意に少。 https://t.co/kCIIgLQYyf
    view full post

    July 26, 2021

    1

    1

  • OHDSI
    @OHDSI (Twitter)

    @HyperAHA The study, which used tools & practices developed within OHDSI to analyze claims & EHR data from nearly 3 million patients worldwide, is the largest to compare the safety and efficacy of ACEs & ARBs, 2 commonly prescribed antihypertensive drugs. STUDY: https://t.co/BKss8Df3NG https://t.co/ooBfgshwMQ
    view full post

    July 26, 2021

  • Dataemia
    @Dataemia (Twitter)

    (Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study) https://t.co/ngRcB9HAmy
    view full post

    July 26, 2021

Abstract Synopsis

  • The study compares the effectiveness and safety of ACE inhibitors and Angiotensin Receptor Blockers (ARBs) in various patient populations.
  • It uses data from multiple countries, focusing on real-world outcomes in patients who are prescribed these medications.
  • The findings aim to inform medical professionals about the best options for managing conditions like hypertension and heart failure.